Suppr超能文献

[倍他洛尔(贝他索洛尔)治疗原发性青光眼的效果]

[Results of the use of betoptik (betaxolol) in the treatment of primary glaucoma].

作者信息

Ermakova V N, Buromskaia A M, Davydova N G, Kolomoĭtseva E M

出版信息

Vestn Oftalmol. 1992 Jan-Feb;108(1):12-4.

PMID:1585527
Abstract

Effect of instillations of 0.5% betaxolol solution (Alcon) on intraocular pressure, ocular hydro- and hemodynamics, function, systemic arterial pressure, and pulse was studied in 35 patients (57 eyes) with primary open-angle glaucoma. The effects of betoptic and arutimol on the eyes are compared. Betoptic is characterized by a marked hypotensive effect explained by depression of aqueous humor production. The drug does not influence ocular function and hemodynamics. Comparison of the hypotensive effects of betaxolol and arutimol has shown that arutimol more effectively reduces intraocular pressure.

摘要

在35例(57只眼)原发性开角型青光眼患者中,研究了滴注0.5%倍他洛尔溶液(爱尔康公司生产)对眼压、眼内水动力学和血液动力学、功能、体动脉压及脉搏的影响。比较了贝他根和阿鲁替莫对眼部的作用。贝他根具有显著的降压作用,这是由于房水生成减少所致。该药物不影响眼功能和血液动力学。倍他洛尔和阿鲁替莫降压作用的比较表明,阿鲁替莫能更有效地降低眼压。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验